Relapse, Survivorship & Monitoring for wAIHA

Achieving a stable hemoglobin level is a major milestone, but for many patients, warm Autoimmune Hemolytic Anemia (wAIHA) is a chronic condition that requires long-term vigilance ^[1]. Survivorship in wAIHA is not just about the absence of anemia; it is about monitoring for potential relapses, managing the long-term side effects of treatment, and preventing complications like blood clots ^[2][3].

The “Relapsing” Nature of wAIHA

It is important to understand the difference between a response and a remission:

• Partial Response: Your hemoglobin has improved significantly (usually over 10 g/dL) but hasn’t reached the normal range ^[4].
• Complete Remission: Your hemoglobin is in the normal range (usually ≥12 g/dL), and signs of hemolysis (like high LDH) have disappeared ^[4].

Even in complete remission, wAIHA can return (relapse). However, there is a “silver lining”: some studies suggest that if a patient remains in clinical remission for at least 15 months after stopping treatment, the risk of a future relapse may be significantly lower ^[5].

Identifying Relapse Risks

While every patient is different, certain markers may help your doctor predict if your disease is more likely to be aggressive or return:

• Dual Positivity: If your Direct Antiglobulin Test (DAT) is positive for both IgG and C3d (complement), it may indicate a higher risk for a severe or refractory course ^[6][7].
• Previous Relapses: Patients who have relapsed once after steroid treatment may have a higher chance of needing more intensive long-term therapy compared to those who are “refractory” (never responded at all) ^[8].

Monitoring: Your Safety Net

In the beginning, you may have blood tests every week. As your counts stabilize, these visits will be spaced out. A standard monitoring schedule typically includes:

1. Complete Blood Count (CBC): To check your hemoglobin ^[1].
2. Hemolysis Markers: LDH, Bilirubin, and Reticulocyte counts to ensure the immune system hasn’t quietly restarted its attack ^[1].
3. Physical Awareness: You are often the first to know if a relapse is starting. Watch for the return of “early warning signs” like unusual fatigue, dark urine, or yellowing of the eyes ^[1][9].

Daily Management and Lifestyle

Living with wAIHA requires adjusting to your body’s energy levels, especially early in your diagnosis:

• Managing Fatigue: Profound fatigue is often the most debilitating symptom. While waiting for treatments to work, rest is crucial. Light activities are okay, but listen to your body and avoid overexertion ^[2].
• Dietary Considerations: Maintain a balanced diet and take your prescribed folic acid to give your bone marrow the building blocks it needs ^[1].

Managing Complications

The Risk of Blood Clots (VTE)

Active hemolysis—the breaking down of red blood cells—makes the blood “sticky” and significantly increases the risk of Venous Thromboembolism (VTE), which includes deep vein thrombosis (DVT) or pulmonary embolisms ^[3].

• Prevention: Current guidelines recommend an individualized risk assessment for every patient ^[10]. If you are in an active flare or hospitalized, your doctor may prescribe blood thinners (thromboprophylaxis) to prevent clots ^[10][11].

Long-Term Treatment Effects

Corticosteroids are effective but come with a “cost” when used long-term. Potential side effects include:

• Bone Health: Increased risk of osteoporosis or fractures ^[2].
• Metabolic Changes: Risk of diabetes mellitus, high blood pressure, and weight gain ^[2][12].
• Infection Risk: A suppressed immune system can make you more vulnerable to serious infections like pneumonia ^[2].

Because of these risks, your care team will prioritize steroid-sparing strategies—moving to other treatments like Rituximab as soon as possible to reduce your total steroid exposure ^[13][2].